The Food and Drug Administration (FDA) approved the injectable drug for patients with hard-to-treat melanoma, the deadliest form of skin cancer that is expected to be diagnosed in 74,000 U.S. patients this year.
Posted on 27 October 2015.
The Food and Drug Administration (FDA) approved the injectable drug for patients with hard-to-treat melanoma, the deadliest form of skin cancer that is expected to be diagnosed in 74,000 U.S. patients this year.
Posted in Healthy LifestyleComments (0)